Fig. 6: β6 integrin-driven invasion is EP300/MMP13 dependent in a physiologically relevant ductal model of DCIS. | npj Breast Cancer

Fig. 6: β6 integrin-driven invasion is EP300/MMP13 dependent in a physiologically relevant ductal model of DCIS.

From: TGFβ-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression

Fig. 6

Primary luminal and myoepithelial cell ductal structures are formed 14 days after embedding into collagen gels and subsequently treated with doxycycline (1 µg/mL) for a further 7 days to induce transgene expression. To inhibit activity of MMP13 and EP300, ducts were treated with MMP13i (CAS-544678 85-5 1 µM) and EP300i (SGCCBP30 1 µM), respectively. a Representative light micrographs of ductal structure at 14 days post embedding. b Imaris reconstructions of luminal/myoepithelial ductal structures after 21 days of culture with HER2 luminal expression −/+ myoepithelial β6 expression and inhibition of MMP13 or EP300 where Nuclei (blue), Vimentin (magenta), HER2 (green) and Cleaved Collagen (yellow). Scale bar = 20 µm.

Back to article page